UroAlert - GU Oncology DailySent on 23 June 2026
Individualizing Systemic Therapy Strategies in Prostate CancerSent on 23 June 2026
Optimizing PSMA Radioligand Therapy in Advanced Prostate CancerSent on 22 June 2026
UroAlert - GU Oncology DailySent on 22 June 2026
Individualizing Treatment Intensification in mHSPCSent on 21 June 2026
Evolving Strategies in Localized Prostate Cancer: Treatment Intensification, Imaging, and Risk StratificationSent on 19 June 2026
UroAlert - GU Oncology DailySent on 19 June 2026
Bladder-Sparing Treatment Decisions in BCG-Unresponsive NMIBCSent on 18 June 2026
UroAlert - GU Oncology DailySent on 18 June 2026
UroAlert - GU Oncology DailySent on 17 June 2026
Biomarkers, EZH2 Targeting, and Treatment Selection in Advanced Prostate CancerSent on 17 June 2026
From Mechanism to Practice: Radiopharmaceutical Therapy in Prostate CancerSent on 16 June 2026
UroAlert - GU Oncology DailySent on 16 June 2026
UroAlert - GU Oncology DailySent on 15 June 2026
High-Risk NMIBC: Bladder Preservation, BCG Challenges, and Evolving Treatment PathwaysSent on 13 June 2026
FDA Approval in PTEN-Deficient Androgen Pathway Modulation-Naïve or -Sensitive Prostate CancerSent on 12 June 2026
Experts Discuss Bladder Cancer Controversies: Rapid-Fire DebatesSent on 12 June 2026
UroAlert - GU Oncology DailySent on 12 June 2026
UroAlert - GU Oncology DailySent on 11 June 2026
Patient Selection, Imaging, and Sequencing in PSMA-Targeted Prostate Cancer CareSent on 11 June 2026
Investigational Approaches in Advanced Prostate CancerSent on 10 June 2026
UroAlert - GU Oncology DailySent on 10 June 2026
Improving Bladder-Sparing Decisions in NMIBCSent on 09 June 2026
UroAlert - GU Oncology DailySent on 09 June 2026
UroAlert - GU Oncology DailySent on 08 June 2026
UroAlert - GU Oncology DailySent on 05 June 2026
Rethinking Treatment Pathways in Recurrent Low-Grade NMIBCSent on 04 June 2026
UroAlert - GU Oncology DailySent on 04 June 2026
UroAlert - GU Oncology DailySent on 03 June 2026
ASCO 2026 Radioligand Therapy Advances Across Prostate CancerSent on 02 June 2026
UroAlert - GU Oncology DailySent on 02 June 2026
ASCO 2026 Prostate Cancer Advances Across the Disease ContinuumSent on 01 June 2026
ASCO 2026 Advancing Curative Strategies in Bladder and Kidney CancerSent on 01 June 2026
UroAlert - GU Oncology DailySent on 01 June 2026
Key Prostate Cancer Insights From Day 3 at ASCOSent on 31 May 2026
ASCO 2026 Matching Prostate Cancer Treatment to Risk, Response, and Patient BenefitSent on 31 May 2026
Novel Approaches to Curing Bladder and Kidney Cancer at ASCO 2026Sent on 30 May 2026
Emerging RCC and Bladder Cancer Data From ASCO Day 1Sent on 30 May 2026
UroAlert - GU Oncology DailySent on 29 May 2026
Navigating Treatment Decisions as Prostate Cancer ProgressesSent on 28 May 2026
UroAlert - GU Oncology DailySent on 28 May 2026
UroAlert - GU Oncology DailySent on 27 May 2026
Emerging Strategies Shaping PSMA-Directed Prostate Cancer CareSent on 27 May 2026
Key GU Oncology Data to Watch at ASCO 2026Sent on 26 May 2026
UroAlert - GU Oncology DailySent on 26 May 2026
UroAlert - GU Oncology DailySent on 25 May 2026
Treatment Intensification, Monitoring, and Emerging Therapies in Prostate CancerSent on 24 May 2026
Making Bladder-Sparing Decisions in High-Risk NMIBCSent on 23 May 2026
AUA-IBCG Bladder Cancer Forum: Debating the Future of Bladder Cancer CareSent on 22 May 2026
UroAlert - GU Oncology DailySent on 22 May 2026
  • Page of 117
Display #
Results 1 - 50 out of 5832